| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Fumitaka Shimizu, Masayuki Nakamor. Blood-Brain Barrier Disruption in Neuroimmunological Disease. International journal of molecular sciences. vol 25. issue 19. 2024-10-16. PMID:39408955. |
this review highlights the pathological contribution of bbb dysfunction to neuroimmunological diseases, including multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), myelin oligodendrocyte glycoprotein antibody-associated disease (mogad), autoimmune encephalitis (ae), and paraneoplastic neurological syndrome (pns). |
2024-10-16 |
2024-10-18 |
Not clear |
| Ann-Kathrin Kogel, Theodoros Ladopoulos, Carolin Schwake, Ingo Kleiter, Bianca Teegen, Nadine Siems, Christian Prehn, Solveig Lichtenberg, Marius Ringelstein, Orhan Aktas, Refik Pul, Britta Krieger, Carsten Lukas, Iris-Katharina Penner, Ralf Gold, Ruth Schneider, Ilya Ayzenber. Cognitive Impairment, Associated Clinical Factors, and MR Volumetric Measures in Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disease. Neurology(R) neuroimmunology & neuroinflammation. vol 11. issue 6. 2024-10-11. PMID:39393044. |
cognitive impairment is a common and challenging symptom in multiple sclerosis and neuromyelitis optica spectrum disease; however, data in myelin oligodendrocyte glycoprotein-igg-associated disease (mogad) remain scarce. |
2024-10-11 |
2024-10-14 |
Not clear |
| Hyun Ji Lyou, Ha Young Shin, Hye Lim Lee, Young Nam Kwon, Seong-Il Oh, Jeeyoung Oh, Eun Bin Cho, Sunyoung Kim, Seol-Hee Baek, Byung-Jo Kim, Eunhee Sohn, Jin Myoung Seok, Ju-Hong Min, Seung Woo Kim, Byoung Joon Ki. Quality of life in patients with myelin oligodendrocyte glycoprotein antibody associated disease compared to patients with AQP4-IgG positive neuromyelitis optica spectrum disorders: A Korean multicenter study. Multiple sclerosis and related disorders. vol 91. 2024-10-06. PMID:39369629. |
quality of life in patients with myelin oligodendrocyte glycoprotein antibody associated disease compared to patients with aqp4-igg positive neuromyelitis optica spectrum disorders: a korean multicenter study. |
2024-10-06 |
2024-10-09 |
Not clear |
| T J Hartung, F Bartels, J Kuchling, S Krohn, J Leidel, M Mantwill, K Wurdack, S Yogeshwar, M Scheel, C Fink. MRI findings in autoimmune encephalitis. Revue neurologique. 2024-10-02. PMID:39358087. |
in some nmda receptor encephalitis cases, these t2-hyperintense lesions may be indicative of an nmda receptor encephalitis overlap syndrome with simultaneous co-existence of multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd) or myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). |
2024-10-02 |
2024-10-05 |
Not clear |
| Omar Abdel-Mannan, Yael Hacohe. Pediatric inflammatory leukoencephalopathies. Handbook of clinical neurology. vol 204. 2024-09-25. PMID:39322390. |
myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) and aquaporin 4-antibody-positive neuromyelitis optica spectrum disorder (aqp4-nmosd) were once considered variants of ms; however, studies in the last decade have established that these are in fact distinct entities. |
2024-09-25 |
2024-09-28 |
Not clear |
| Priyanka S Aher, Deepaswi Bhavsar, Sumit Toshniwal, Riddhi A Bora, Rohan Jagadis. Neuromyelitis Optica: A Peek Into the Brain Through the Eyes. Cureus. vol 16. issue 8. 2024-09-24. PMID:39310466. |
blood tests revealed positive neuromyelitis optica myelin oligodendrocyte glycoprotein antibodies after which diagnosis of neuromyelitis optica was made. |
2024-09-24 |
2024-09-26 |
Not clear |
| R Marignie. What's new in NMOSD and MOGAD? Revue neurologique. 2024-09-14. PMID:39277477. |
in this mini-review, we focus on novelties in the field of neuromyelitis optica spectrum disorders (nmosd) and myelin oligodendrocyte glycoprotein antibody associated disease (mogad). |
2024-09-14 |
2024-09-18 |
Not clear |
| Mobina Amanollahi, Mehrdad Mozafar, Saeid Rezaei, Ali Rafati, Helia Ashourizadeh, Negar Moheb, Melika Jameie, Parnian Shobeiri, John J Che. Optical coherence tomography angiography measurements in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody disease: A systematic review and meta-analysis. Multiple sclerosis and related disorders. vol 91. 2024-09-12. PMID:39265270. |
optical coherence tomography angiography measurements in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody disease: a systematic review and meta-analysis. |
2024-09-12 |
2024-09-15 |
Not clear |
| Mobina Amanollahi, Mehrdad Mozafar, Saeid Rezaei, Ali Rafati, Helia Ashourizadeh, Negar Moheb, Melika Jameie, Parnian Shobeiri, John J Che. Optical coherence tomography angiography measurements in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody disease: A systematic review and meta-analysis. Multiple sclerosis and related disorders. vol 91. 2024-09-12. PMID:39265270. |
neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody disease (mogad) are immune-mediated disorders that can often manifest with optic neuritis (on) among other symptoms. |
2024-09-12 |
2024-09-15 |
Not clear |
| M M Samim, Rupam Mandal, Jigil Joy, Debjyoti Dhar, Kshiteeja Jain, Anita Mahadevan, M Netravath. Spectrum of Auto-antibodies in NMO and MOG Associated CNS Demyelination- The SANMAD Study. Journal of neuroimmunology. vol 396. 2024-09-08. PMID:39244918. |
this observational study explored coexisting organ-specific and non-organ-specific autoantibodies in neuromyelitis optica spectrum disorder(nmosd) and myelin oligodendrocyte glycoprotein-igg-1(mog-igg1) associated central nervous system demyelination(mogad) in a south asian cohort from march 2017-2023. |
2024-09-08 |
2024-09-11 |
Not clear |
| Li-Tal Pratt, Hadas Meirson, Mika Shapira Rootman, Liat Ben-Sira, Shelly I Shira. Radiological features in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease-diagnostic criteria and lesion dynamics. Pediatric radiology. 2024-09-07. PMID:39243314. |
the spectrum of acquired pediatric demyelinating syndromes has been expanding over the past few years, to include myelin oligodendrocyte glycoprotein antibody-associated disease (mogad), as a distinct neuroimmune entity, in addition to pediatric-onset multiple sclerosis (poms) and aquaporin 4-igg-seropositive neuromyelitis optica spectrum disorder (aqp4+nmosd). |
2024-09-07 |
2024-09-10 |
Not clear |
| Yuan Cao, Wen Yao, Fang Che. Brief research report: WGCNA-driven identification of histone modification genes as potential biomarkers in AQP4-Associated optic neuritis. Frontiers in genetics. vol 15. 2024-09-06. PMID:39238786. |
the discovery of antibodies aqp4 and myelin oligodendrocyte glycoprotein (mog) has expanded our understanding of the pathogenesis of neuromyelitis optica. |
2024-09-06 |
2024-09-08 |
Not clear |
| Dalia L Rotstein, Mark S Freedman, Andrea Konig, Liesly Lee, Jin Luo, Colleen Maxwell, Sarah A Morrow, Helen Tremlett, Manav V Vyas, Ruth Ann Marri. Investigation of health care use and a possible prodrome before the first attack in NMOSD and MOGAD. Multiple sclerosis (Houndmills, Basingstoke, England). 2024-09-05. PMID:39234853. |
we evaluated the possibility of a prodrome in aquaporin-4 antibody positive (aqp4+) neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody disease (mogad) using health administrative data. |
2024-09-05 |
2024-09-08 |
Not clear |
| Giulio Volpe, Neringa Jurkute, Gabriela Girafa, Hanna G Zimmermann, Seyedamirhosein Motamedi, Charlotte Bereuter, Lekha Pandit, Anitha D'Cunha, Michael R Yeaman, Terry J Smith, Lawrence J Cook, Alexander U Brandt, Friedemann Paul, Axel Petzold, Frederike C Oerte. Diagnostic Value of Inter-Eye Difference Metrics on OCT for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis. Neurology(R) neuroimmunology & neuroinflammation. vol 11. issue 6. 2024-09-04. PMID:39231384. |
the diagnostic value of intereye difference (ied) metrics is high for on in patients with multiple sclerosis and aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders, but unknown in myelin oligodendrocyte glycoprotein antibody-associated on (mog-on). |
2024-09-04 |
2024-09-08 |
Not clear |
| Masaaki Niino, Noriko Isobe, Manabu Araki, Takashi Ohashi, Tomoko Okamoto, Mieko Ogino, Tatsusada Okuno, Hirofumi Ochi, Izumi Kawachi, Yuko Shimizu, Kazuya Takahashi, Hideyuki Takeuchi, Masayuki Tahara, Norio Chihara, Ichiro Nakashima, Hikoaki Fukaura, Tatsuro Misu, Yusei Miyazaki, Katsuichi Miyamoto, Masahiro Mori, Makoto Kinoshita, Yoshiki Takai, Chihiro Fujii, Mitsuru Watanabe, Kazuo Fujihar. Clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in Japan. Multiple sclerosis and related disorders. vol 90. 2024-08-25. PMID:39182455. |
clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in japan. |
2024-08-25 |
2024-08-28 |
Not clear |
| Debamita Datta, Mala Mahto, Upasna Sinha, Sushil Kuma. Indirect Immunofluorescence-Aided Detection of Antimyelin Oligodendrocyte Glycoprotein Antibodies in Neuromyelitis Optica Spectrum Disorder/Myelin Oligodendrocyte Glycoprotein-Associated Antibody Disorder: A Case Series Involving Five Patients. Annals of African medicine. 2024-08-14. PMID:39138928. |
indirect immunofluorescence-aided detection of antimyelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder/myelin oligodendrocyte glycoprotein-associated antibody disorder: a case series involving five patients. |
2024-08-14 |
2024-08-16 |
Not clear |
| Kimihiko Kaneko, Hiroshi Kuroda, Yuki Matsumoto, Naohiro Sakamoto, Naoya Yamazaki, Naoki Yamamoto, Shu Umezawa, Chihiro Namatame, Hirohiko Ono, Yoshiki Takai, Toshiyuki Takahashi, Juichi Fujimori, Ichiro Nakashima, Yasuo Harigaya, Hans Lassmann, Kazuo Fujihara, Tatsuro Misu, Masashi Aok. Different Complement Activation Patterns Following C5 Cleavage in MOGAD and AQP4-IgG+NMOSD. Neurology(R) neuroimmunology & neuroinflammation. vol 11. issue 5. 2024-08-12. PMID:39133885. |
in myelin oligodendrocyte glycoprotein igg-associated disease (mogad) and aquaporin-4 igg+ neuromyelitis optica spectrum disorder (aqp4+nmosd), the autoantibodies are mainly composed of igg1, and complement-dependent cytotoxicity is a primary pathomechanism in aqp4+nmosd. |
2024-08-12 |
2024-08-16 |
Not clear |
| Giuseppe Schirò, Salvatore Iacono, Giuseppe Salemi, Paolo Ragones. The pharmacological management of myelin oligodendrocyte glycoprotein-immunoglobulin G associated disease (MOGAD): an update of the literature. Expert review of neurotherapeutics. 2024-08-07. PMID:39110029. |
myelin oligodendrocyte glycoprotein-immunoglobulin g associated disease (mogad) is a clinical entity distinct from multiple sclerosis and aquaporin-4 (aqp4+)-igg-positive neuromyelitis optica spectrum disorder. |
2024-08-07 |
2024-08-09 |
Not clear |
| Elia Sech. NMOSD and MOGAD. Continuum (Minneapolis, Minn.). vol 30. issue 4. 2024-08-01. PMID:39088288. |
this article reviews the clinical features, mri characteristics, diagnosis, and treatment of aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (aqp4-nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). |
2024-08-01 |
2024-08-05 |
Not clear |
| Étienne Bénard-Séguin, Christopher Nielsen, Abdullah Sarhan, Abdullah Al-Ani, Antoine Sylvestre-Bouchard, Derek M Waldner, Lindsey B De Lott, Suresh Subramaniam, Fiona Costell. The Role of Artificial Intelligence in Predicting Optic Neuritis Subtypes From Ocular Fundus Photographs. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2024-08-01. PMID:39088711. |
notably, on associated with multiple sclerosis (ms on) has a good prognosis for recovery irrespective of treatment, whereas on associated with other conditions including neuromyelitis optica spectrum disorders or myelin oligodendrocyte glycoprotein antibody-associated disease is often associated with less favorable outcomes. |
2024-08-01 |
2024-08-05 |
Not clear |